VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Friday, January 2, 2026
Stock Comparison
Novartis AG vs Pro Medicus Limited
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Novartis AG
NOVN · SIX Swiss Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Novartis AG's moat claims, evidence, and risks.
View NOVN analysisPro Medicus Limited
PME · ASX
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Pro Medicus Limited's moat claims, evidence, and risks.
View PME analysisComparison highlights
- Moat score gap: Pro Medicus Limited leads (80 / 100 vs 65 / 100 for Novartis AG).
- Segment focus: Novartis AG has 5 segments (29.3% in Oncology); Pro Medicus Limited has 2 segments (92.5% in Visage 7 Enterprise Imaging Platform (PACS / CloudPACS)).
- Moat breadth: Novartis AG has 4 moat types across 3 domains; Pro Medicus Limited has 6 across 2.
Primary market context
Novartis AG
Oncology
Oncology and hematology branded medicines (including targeted therapies and radioligand therapy)
Global
Oncologists and hospitals; reimbursed by payers; hospital and specialty pharmacy channels
Originator developer, manufacturer, and marketer of oncology therapies
29.3%
Pro Medicus Limited
Visage 7 Enterprise Imaging Platform (PACS / CloudPACS)
Enterprise imaging / PACS and related modules for hospitals and integrated delivery networks (IDNs)
Primarily North America; also Europe and Australia
Hospitals, imaging centers, integrated delivery networks (IDNs)
Healthcare IT software vendor / platform provider
92.5%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
Novartis AG strengths
Pro Medicus Limited strengths
Segment mix
Novartis AG segments
Full profile >Cardiovascular, Renal and Metabolic
Oligopoly
Immunology
Oligopoly
Neuroscience
Oligopoly
Oncology
Oligopoly
Established Brands
Competitive
Pro Medicus Limited segments
Full profile >Visage 7 Enterprise Imaging Platform (PACS / CloudPACS)
Oligopoly
Visage RIS (Radiology Information System) and Promedicus.net
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.